Active	Status	Sponsor type	Region	Phase	Filter
1 Active 6 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zeltzer, Lonnie K
NCT02247843: Stem Cell Gene Therapy for Sickle Cell Disease	Active, not recruiting	1/2	4	US	βAS3-FB vector transduced peripheral blood CD34+ cells, Lenti/βAS3-FB	Donald B. Kohn, M.D., California Institute for Regenerative Medicine (CIRM)	Sickle Cell Disease	12/25	12/25